本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Kymera Therapeutics, Inc.

46.18
-0.1700-0.37%
盘后46.180.00000.00%17:31 EDT
成交量:50.15万
成交额:2,329.40万
市值:32.40亿
市盈率:-14.84
高:47.30
开:46.74
低:46.00
收:46.35
数据加载中...
2024/07/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/08

重要事件披露

Form 8-K - Current report
2024/06/20

重要事件披露

Form 8-K - Current report
2024/06/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/02

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/02

重要事件披露

Form 8-K - Current report
2024/04/01

超过5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2024/04/01

重要事件披露

Form 8-K - Current report
2024/03/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities